Quantum BioPharma Q3 EPS $(1.25) Misses $(0.08) Estimate

Quantum BioPharma (NASDAQ: QNTM) reported quarterly losses of $(1.25) per share which missed the analyst consensus estimate of $(0.08) by 1462.5 percent. This is a 71.4 percent increase over losses of $(4.37) per share from the same period last year.